Abstract
Many of organic compounds, such as pharmaceuticals and chemicals, are produced as crystals. Controlling the characteristics of these crystal products with good reproducibility is essential for crystallization of organic compounds. There are various characteristics to be controlled, such as grain size and distribution, crystal polymorphism, crystal habit, and purity, but grain size and crystal polymorphism are particularly essential characteristics. In order to control them, the authors have developed several new crystallizers. This chapter highlights some recent crystallizers to produce organic crystals with high quality.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Haleblia, J., Mccrone, W.: Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58, 911 (1969)
Haleblian, J.K.: Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64, 1269–1288 (1975)
Brittain, H.G.: Polymorphism in Pharmaceutical Solids, 2nd edn. Informa Healthcare (2009)
Aguiar, A.J., Krc, J., Kinkel, A.W., Samyn, J.C.: Effect of polymorphism on absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56, 847 (1967)
Ooshima, H., Igarashi, K., Sasaki, Y., Azuma, M., Noda, H.: Production of large crystals of glycine with a narrow size distribution using WWDJ-batch crystallizer. Chem. Eng. Trans. 1, 981–986 (2002)
Noda, H., Yamaji, H., Kuratani, N., Mukaida, T., Ohuchi, M.: Challenge to a precess revolution. Wall Wetter. Kagaku Kougaku 63, 295–296 (1999)
Igarashi, K., Yamanaka, Y., Azuma, M., Ooshima, H.: Control of crystal size distribution using a mL-scale continuous crystallizer equipped with a high speed agitator. J. Chem. Eng. Jpn. 45, 28–33 (2012)
Bittner, B., Mountfield, R.J.: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters. Curr. Opin. Drug Discov. Devel. 5, 59–71 (2002)
Kakran, M., Sahoo, N.G., Li, L., Judeh, Z., Wang, Y., Chong, K., Loh, L.: Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int. J. Pharm. 383, 285–292 (2010)
Lechuga-Ballesteros, D., & RodrÃguez-Hornedo, N. (1995). Effects of molecular structure and growth kinetics on the morphology of l-alanine crystals. International Journal of Pharmaceutics, 115(2), 151–160.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Igarashi, K., Ooshima, H. (2020). Control of Crystal Size Distribution and Polymorphs in the Crystallization of Organic Compounds. In: Sakamoto, M., Uekusa, H. (eds) Advances in Organic Crystal Chemistry. Springer, Singapore. https://doi.org/10.1007/978-981-15-5085-0_5
Download citation
DOI: https://doi.org/10.1007/978-981-15-5085-0_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5084-3
Online ISBN: 978-981-15-5085-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)